【4548】生化学工業

医薬品。関節機能改善剤。

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2024.03	2024/02/14	Q3予	36,100	→	0.0%	+10.9%	1,300	→	0.0%	+1200.0%	2,250	→	0.0%	+45.2%	2,600	→	0.0%	+79.3%
2024.03	2023/11/08	Q2予	36,100	↑	+10.9%	+10.9%	1,300	↑	+1200.0%	+1200.0%	2,250	↑	+45.2%	+45.2%	2,600	↑	+79.3%	+79.3%
2024.03	2023/08/04	Q1予	32,550	→	0.0%	0.0%	100	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,450	→	0.0%	0.0%
2024.03	2023/05/12	当初予	32,550	-	-	-	100	-	-	-	1,550	-	-	-	1,450	-	-	-
2023.03	2023/05/12	実	33,456	↓	-0.1%	-0.1%	2,114	↑	+24.4%	+24.4%	3,069	↑	+5.8%	+5.8%	2,236	↓	-15.6%	-15.6%
2023.03	2023/02/08	Q3予	33,500	→	0.0%	0.0%	1,700	→	0.0%	0.0%	2,900	→	0.0%	0.0%	2,650	→	0.0%	0.0%
2023.03	2022/11/08	当初予	33,500	-	-	-	1,700	-	-	-	2,900	-	-	-	2,650	-	-	-
2022.03	2022/05/13	実	34,851	↑	+8.2%	+8.2%	4,495	↓	-1.2%	-1.2%	5,395	↑	+16.0%	+16.0%	3,733	↑	+2.3%	+2.3%
2022.03	2022/02/08	Q3予	32,200	→	0.0%	0.0%	4,550	→	0.0%	0.0%	4,650	→	0.0%	0.0%	3,650	→	0.0%	0.0%
2022.03	2021/11/09	Q2予	32,200	→	0.0%	0.0%	4,550	→	0.0%	0.0%	4,650	→	0.0%	0.0%	3,650	→	0.0%	0.0%
2022.03	2021/07/30	Q1予	32,200	→	0.0%	0.0%	4,550	→	0.0%	0.0%	4,650	→	0.0%	0.0%	3,650	→	0.0%	0.0%
2022.03	2021/05/13	当初予	32,200	-	-	-	4,550	-	-	-	4,650	-	-	-	3,650	-	-	-
2021.03	2021/05/13	実	27,662	↓	-0.3%	+3.8%	1,530	↓	-10.0%	+178.2%	3,024	↓	-5.5%	+116.0%	4,262	↓	-0.9%	+270.6%
2021.03	2021/04/27	修正予	27,750	↑	+0.9%	+4.1%	1,700	↑	+100.0%	+209.1%	3,200	↑	+56.1%	+128.6%	4,300	↑	+152.9%	+273.9%
2021.03	2021/02/05	修正予	27,500	↑	+3.2%	+3.2%	850	↑	+54.5%	+54.5%	2,050	↑	+46.4%	+46.4%	1,700	↑	+47.8%	+47.8%
2021.03	2020/11/11	Q2予	26,650	→	0.0%	0.0%	550	→	0.0%	0.0%	1,400	→	0.0%	0.0%	1,150	→	0.0%	0.0%
2021.03	2020/09/24	当初予	26,650	-	-	-	550	-	-	-	1,400	-	-	-	1,150	-	-	-
2020.03	2020/05/19	実	28,642	↑	+0.1%	+1.4%	1,960	↑	+45.2%	+390.0%	3,981	↑	+6.2%	+73.1%	-10,839	↑	+1.5%	-642.0%
2020.03	2020/02/04	Q3予	28,600	→	0.0%	+1.2%	1,350	→	0.0%	+237.5%	3,750	→	0.0%	+63.0%	-11,000	→	0.0%	-650.0%
2020.03	2019/11/08	Q2予	28,600	↑	+1.2%	+1.2%	1,350	↑	+237.5%	+237.5%	3,750	↑	+63.0%	+63.0%	-11,000	↓	-650.0%	-650.0%
2020.03	2019/07/31	Q1予	28,250	→	0.0%	0.0%	400	→	0.0%	0.0%	2,300	→	0.0%	0.0%	2,000	→	0.0%	0.0%
2020.03	2019/05/10	当初予	28,250	-	-	-	400	-	-	-	2,300	-	-	-	2,000	-	-	-
2019.03	2019/05/10	実	28,384	↑	+0.1%	+1.0%	977	↑	+2.8%	+144.3%	2,859	↑	+2.1%	+27.1%	2,244	↑	+2.0%	+32.0%
2019.03	2019/04/23	修正予	28,350	↑	+0.9%	+0.9%	950	↑	+137.5%	+137.5%	2,800	↑	+24.4%	+24.4%	2,200	↑	+29.4%	+29.4%
2019.03	2019/02/05	Q3予	28,100	→	0.0%	0.0%	400	→	0.0%	0.0%	2,250	→	0.0%	0.0%	1,700	→	0.0%	0.0%
2019.03	2018/11/07	Q2予	28,100	→	0.0%	0.0%	400	→	0.0%	0.0%	2,250	→	0.0%	0.0%	1,700	→	0.0%	0.0%
2019.03	2018/07/31	Q1予	28,100	→	0.0%	0.0%	400	→	0.0%	0.0%	2,250	→	0.0%	0.0%	1,700	→	0.0%	0.0%
2019.03	2018/05/11	当初予	28,100	-	-	-	400	-	-	-	2,250	-	-	-	1,700	-	-	-
2018.03	2018/05/11	実	30,175	↑	+0.2%	-0.4%	1,421	↓	-5.3%	-5.3%	5,327	↑	+1.5%	+42.1%	3,922	↑	+3.2%	+45.3%
2018.03	2018/03/30	修正予	30,100	↓	-0.7%	-0.7%	-	-	-	-	5,250	↑	+40.0%	+40.0%	3,800	↑	+40.7%	+40.7%
2018.03	2018/02/02	Q3予	30,300	→	0.0%	0.0%	1,500	→	0.0%	0.0%	3,750	→	0.0%	0.0%	2,700	→	0.0%	0.0%
2018.03	2017/11/07	Q2予	30,300	→	0.0%	0.0%	1,500	→	0.0%	0.0%	3,750	→	0.0%	0.0%	2,700	→	0.0%	0.0%
2018.03	2017/07/31	Q1予	30,300	→	0.0%	0.0%	1,500	→	0.0%	0.0%	3,750	→	0.0%	0.0%	2,700	→	0.0%	0.0%
2018.03	2017/05/12	当初予	30,300	-	-	-	1,500	-	-	-	3,750	-	-	-	2,700	-	-	-
2017.03	2017/05/12	実	29,589	↓	-0.2%	+0.1%	1,282	↑	+2.6%	+28.2%	2,477	↓	-6.5%	-26.1%	1,787	↓	-10.7%	-29.9%
2017.03	2017/02/03	Q3予	29,650	→	0.0%	+0.3%	1,250	→	0.0%	+25.0%	2,650	→	0.0%	-20.9%	2,000	→	0.0%	-21.6%
2017.03	2016/11/08	Q2予	29,650	↑	+0.3%	+0.3%	1,250	↑	+25.0%	+25.0%	2,650	↓	-20.9%	-20.9%	2,000	↓	-21.6%	-21.6%
2017.03	2016/07/28	Q1予	29,550	→	0.0%	0.0%	1,000	→	0.0%	0.0%	3,350	→	0.0%	0.0%	2,550	→	0.0%	0.0%
2017.03	2016/05/12	当初予	29,550	-	-	-	1,000	-	-	-	3,350	-	-	-	2,550	-	-	-
2016.03	2016/05/12	実	30,962	↑	+1.0%	+1.0%	2,144	↓	-10.7%	-10.7%	3,500	↓	-7.9%	-7.9%	2,578	↓	-11.1%	-11.1%
2016.03	2016/02/02	Q3予	30,650	→	0.0%	0.0%	2,400	→	0.0%	0.0%	3,800	→	0.0%	0.0%	2,900	→	0.0%	0.0%
2016.03	2015/11/06	Q2予	30,650	→	0.0%	0.0%	2,400	→	0.0%	0.0%	3,800	→	0.0%	0.0%	2,900	→	0.0%	0.0%
2016.03	2015/07/31	Q1予	30,650	→	0.0%	0.0%	2,400	→	0.0%	0.0%	3,800	→	0.0%	0.0%	2,900	→	0.0%	0.0%
2016.03	2015/05/12	当初予	30,650	-	-	-	2,400	-	-	-	3,800	-	-	-	2,900	-	-	-
2015.03	2015/05/12	実	29,522	↑	+1.3%	+1.3%	2,383	↓	-13.3%	-13.3%	4,008	↓	-4.6%	-4.6%	3,650	↑	+5.8%	+5.8%
2015.03	2015/02/03	Q3予	29,150	→	0.0%	0.0%	2,750	→	0.0%	0.0%	4,200	→	0.0%	0.0%	3,450	→	0.0%	0.0%
2015.03	2014/11/07	Q2予	29,150	→	0.0%	0.0%	2,750	→	0.0%	0.0%	4,200	→	0.0%	0.0%	3,450	→	0.0%	0.0%
2015.03	2014/07/31	Q1予	29,150	→	0.0%	0.0%	2,750	→	0.0%	0.0%	4,200	→	0.0%	0.0%	3,450	→	0.0%	0.0%
2015.03	2014/05/13	当初予	29,150	-	-	-	2,750	-	-	-	4,200	-	-	-	3,450	-	-	-
2014.03	2014/05/13	実	29,614	-	-	-	4,937	-	-	-	5,878	-	-	-	4,745	-	-	-

【4548】生化学工業 医薬品。関節機能改善剤。

業績予想修正履歴

【4548】生化学工業

医薬品。関節機能改善剤。